Section Arrow
Quote
MLTX.NASDAQ
- MoonLake Immunotherapeutics
Quotes are at least 15-min delayed:2025/07/21 18:55 EDT
After Hours
Last
 53.57
0 (0.00%)
Bid
53.2
Ask
55
High 54.1 
Low 53.57 
Volume 21429 
Regular Hours
Last
 53.57
+0.48 (+0.90%)
Day High 
54.41 
Prev. Close
53.09 
1-M High
54.63 
Volume 
233.89K 
Bid
53.2
Ask
55
Day Low
53.03 
Open
53.27 
1-M Low
43.04 
Market Cap 
3.37B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 50.07 
20-SMA 48.38 
50-SMA 44.31 
52-W High 58.26 
52-W Low 31.4201 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.30/-3.15
Enterprise Value
3.37B
Balance Sheet
Book Value Per Share
6.42
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TNFATNF Pharmaceuticals Inc.0.1294+0.0419+47.89%-- 
After Hours 0.1188 -0.0106 -8.19%
NCNANuCana plc0.051+0.0033+6.92%-- 
After Hours 0.0566 +0.0056 +10.98%
PMNProMIS Neurosciences1.12+0.6799+154.49%5PE
After Hours 1.03 -0.09 -8.04%
SABSSAB Biotherapeutics2.7+0.13+5.06%-- 
After Hours 2.64 -0.06 -2.22%
RXRXRecursion Pharmaceuticals6.4+0.56+9.59%-- 
After Hours 6.42 +0.02 +0.31%
Quotes are at least 15-min delayed：2025/07/21 18:55 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.